New Cheek Enhancing Injection Has Been FDA-Approved! Juvederm Voluma XC

Allergan, the makers of Juvederm and Botox, have created the first product specifically formulated to correct age-related volume loss in the cheek area. Juvederm Voluma XC is the latest innovation in Allergan’s growing product line of facial aesthetic products developed, which uses hyaluronic gel suspended in a saline solution to create a natural appearing cheek enhancement.

Having well defined, full cheeks is considered more youthful and appealing than a thin and hollowed out appearance. Fullness to the mid-facial region lifts the lower region giving you a better balance to your overall appearance.

Non-surgical cheek augmentation is a revolutionary new treatment. This non-surgical approach to cheek augmentations provides a treatment to sculpt cheeks without the downtime and discomfort that surgery demands. For those that are surgery averse or are unsure of their decision to permanently enhance their appearance with cosmetic treatments, the Juvederm Voluma XC is an effective approach.

Juvederm Voluma XC is specially designed to add volume into aging cheeks because they have lost the natural fat that was once there with youth. Aside from age, weight loss could be another cause for injectable enhancements, and with the new dermal filler made available, it’s completely possible and instant solution to regain your youthful face. High cheek bones support and uplift the skin and muscles of the face, assisting in the prevention of a premature aged appearance.

If you were born with poorly defined or flat cheekbones, you may want to achieve more refined and sculpted cheekbones, and as long as you’re at least 21 years old, this treatment option is available. Weak cheeks can make your face appear gaunt, and create an aged appearance to the under-eye area. High cheekbones are traditionally associated with balance and beauty of the face and because the procedure is virtually painless, it can easily contour and enhance volume in a natural-appearing way.